Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis

被引:5
|
作者
Keiser, Paul B. [1 ]
Miller, Lori B. [1 ]
Biggs-Cicatelli, Susan [1 ]
Zollinger, Wendell D. [1 ]
机构
[1] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
关键词
Fibrinogen; Vaccine; Neisseria meningitidis; OMV; C-REACTIVE PROTEIN; YELLOW-FEVER VACCINATION; INFLUENZA VACCINATION; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; ASSOCIATION; MORTALITY; ANTIBODY;
D O I
10.1016/j.vaccine.2009.09.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several studies have shown plasma fibrinogen increases following some vaccinations, but the specific triggers and the kinetics of this response are not well understood. We conducted a phase I trial of an outer membrane vesicle vaccine for Neisseria meningitidis. Plasma fibrinogen was measured on days 0, 2 and 14 following each of 3 doses. The highest dose of vaccine was associated with the greatest increase in fibrinogen at day 2, which decreased by day 14. The first vaccination caused a greater increase than either subsequent vaccination. These transient increases in fibrinogen are comparable to what occurs with upper respiratory infections and have not been demonstrated to represent an increased risk of adverse vascular events. Published by Elsevier Ltd.
引用
收藏
页码:6809 / 6813
页数:5
相关论文
共 50 条
  • [41] Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants
    van der Ley, Peter
    van den Dobbelsteen, Germie
    HUMAN VACCINES, 2011, 7 (08): : 886 - 890
  • [42] The β-Barrel Outer Membrane Protein Assembly Complex of Neisseria meningitidis
    Volokhina, Elena B.
    Beckers, Frank
    Tommassen, Jan
    Bos, Martine P.
    JOURNAL OF BACTERIOLOGY, 2009, 191 (22) : 7074 - 7085
  • [43] OUTER-MEMBRANE PROTEIN SEROSUBTYPING OF NEISSERIA-MENINGITIDIS
    POOLMAN, JT
    ABDILLAHI, H
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (02) : 291 - 292
  • [44] Outer membrane proteins and serosubtyping with outer membrane vesicles from clinical isolates of Neisseria meningitidis
    Arhin, FF
    Moreau, F
    Coulton, JW
    Mills, EL
    CURRENT MICROBIOLOGY, 1997, 34 (01) : 18 - 22
  • [45] Outer Membrane Vesicles from Neisseria Meningitidis (Proteossome) Used for Nanostructured Zika Virus Vaccine Production
    Martins, Paula
    Machado, Daisy
    Theizen, Thais Holtz
    Oliveira Guarnieri, Joao Paulo
    Bernardes, Bruno Gaia
    Gomide, Gabriel Piccirillo
    Finzi Corat, Marcus Alexandre
    Abbehausen, Camilla
    Proenca Modena, Jose Luiz
    Odir Rodrigues Melo, Carlos Fernando
    Morishita, Karen Noda
    Catharino, Rodrigo Ramos
    Arns, Clarice Weis
    Lancellotti, Marcelo
    SCIENTIFIC REPORTS, 2018, 8
  • [46] Outer Membrane Vesicles from Neisseria Meningitidis (Proteossome) Used for Nanostructured Zika Virus Vaccine Production
    Paula Martins
    Daisy Machado
    Thais Holtz Theizen
    João Paulo Oliveira Guarnieri
    Bruno Gaia Bernardes
    Gabriel Piccirillo Gomide
    Marcus Alexandre Finzi Corat
    Camilla Abbehausen
    José Luiz Proença Módena
    Carlos Fernando Odir Rodrigues Melo
    Karen Noda Morishita
    Rodrigo Ramos Catharino
    Clarice Weis Arns
    Marcelo Lancellotti
    Scientific Reports, 8
  • [47] Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine
    Vermont, CL
    van Dijken, HH
    Kuipers, AJ
    van Limpt, CJP
    Keijzers, WCM
    van der Ende, A
    de Groot, R
    van Alphen, L
    van den Dobbelsteen, GPJM
    INFECTION AND IMMUNITY, 2003, 71 (04) : 1650 - 1655
  • [48] Outer membrane proteins and serosubtyping with outer membrane vesicles from clinical isolates of Neisseria meningitidis
    Arhin F.F.
    Moreau F.
    Coulton J.W.
    Mills E.L.
    Current Microbiology , 1997, 34 (1 ) : 18 - 22
  • [49] A MENINGOCOCCAL NATIVE OUTER MEMBRANE VESICLE VACCINE AS A PLATFORM FOR PRESENTING CONSERVED GONOCOCCAL ANTIGENS
    Moe, Gregory
    Beernink, Peter
    Vianzon, Vianca
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 : A38 - A38
  • [50] Safety review:: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease
    Nokleby, H.
    Aavitsland, P.
    O'Hallahan, J.
    Feiring, B.
    Tilman, S.
    Oster, P.
    VACCINE, 2007, 25 (16) : 3080 - 3084